Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis: a relevant tool for anticancer therapy.

A Russo1, M Terrasi, V Agnese

  • 1Section of Medical Oncology, Department of Surgical and Oncology, Università di Palermo, Italy. lab-oncobiologia@usa.net

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|June 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.

Cancer·1996
Same author

Intake of macronutrients and risk of breast cancer.

Lancet (London, England)·1996
Same author

Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress.

Metabolism: clinical and experimental·1996
Same author

Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy.

American heart journal·1996
Same author

Pleomorphic adenoma and adenoid-cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow-cytometric study.

Cell proliferation·1996
Same author

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

British journal of cancer·1996
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Targeting apoptosis, a crucial cell death process, offers new cancer treatment strategies. While some therapies are in development, targeting apoptosis pathways shows promise for overcoming cancer drug resistance.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Apoptosis is essential for removing damaged cells and preventing cancer.
  • Defective apoptosis is a key factor in cancer development and progression.
  • Cancer cells often develop resistance to chemotherapy and radiation by altering apoptotic pathways.

Purpose of the Study:

  • To review novel targeted therapies that exploit apoptosis for cancer treatment.
  • To update on molecular players targeting apoptosis, including those in clinical use or evaluation.
  • To highlight potential future anticancer drug programs targeting apoptosis.

Main Methods:

  • Review of current literature on apoptosis and cancer.
  • Analysis of molecular targets within the extrinsic and intrinsic apoptotic pathways.

Related Experiment Videos

  • Evaluation of therapeutic agents targeting apoptosis machinery (e.g., p53, proteasome).

    • Main Results:

    • Several targeted therapies exploiting apoptosis are in preclinical or clinical development.
    • Agents like bortezomib are already in use, while others (e.g., ONYX-015, TRAIL/Apo2L) show promise.
    • Drug resistance remains a challenge, but novel approaches offer potential.

    Conclusions:

    • Targeting apoptosis pathways represents a promising strategy for novel cancer therapies.
    • Further research and clinical evaluation are needed for many apoptosis-targeting agents.
    • Exploiting apoptosis offers a route to overcome resistance in cancer treatment.